These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 3062958

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA.
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [Abstract] [Full Text] [Related]

  • 3. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G.
    Clin Physiol Biochem; 1990 Mar; 8 Suppl 1():6-15. PubMed ID: 2257722
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones.
    Kramer HJ, Glänzer K, Meyer-Lehnert H, Mohaupt M, Predel HG.
    J Cardiovasc Pharmacol; 1990 Mar; 15 Suppl 6():S91-8. PubMed ID: 1697369
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Converting enzyme inhibitors and the interaction between kinins and eicosanoids.
    Schrör K.
    J Cardiovasc Pharmacol; 1990 Mar; 15 Suppl 6():S60-8. PubMed ID: 1697363
    [Abstract] [Full Text] [Related]

  • 8. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE, Julius S.
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
    Andersen RS, Christensen S.
    Ugeskr Laeger; 2001 Dec 10; 163(50):7036-9. PubMed ID: 11794033
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z, Armaly Z, Nakhoul F, Hoffman A.
    Harefuah; 2008 Jun 10; 147(6):536-42, 573. PubMed ID: 18693632
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of enalapril maleate (MK-421) on blood pressure, renin-angiotensin system and kallikrein-kinin system in patients with essential hypertension].
    Shionoiri H, Akema N, Tanaka K, Miyazaki N, Gotoh E, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1984 Jun 10; 26(6):759-65. PubMed ID: 6096606
    [No Abstract] [Full Text] [Related]

  • 15. What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
    Brunner HR, Waeber B, Nussberger J.
    J Hypertens Suppl; 1988 Dec 10; 6(3):S1-5. PubMed ID: 3066876
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
    Shimamoto K, Matsuki T, Iimura O.
    J Cardiovasc Pharmacol; 1990 Dec 10; 15 Suppl 6():S83-90. PubMed ID: 1697368
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Mechanisms of action of angiotensin I converting enzyme inhibitors].
    Wiecek A.
    Przegl Lek; 1994 Dec 10; 51(4):193-7. PubMed ID: 8058992
    [Abstract] [Full Text] [Related]

  • 19. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M, Gohlke P, Paul M, Stoll M, Unger T.
    J Cardiovasc Pharmacol; 1994 Dec 10; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibition in patients with essential hypertension.
    Kramer HJ, Predel HG, Meyer-Lehnert H.
    Clin Physiol Biochem; 1990 Dec 10; 8 Suppl 1():16-24. PubMed ID: 2257720
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.